Positive list system to restrict drug demand will hurt pharmaceutical sector
Published: 2007-06-11 06:57:00
Updated: 2007-06-11 06:57:00
The government is implementing its new drug pricing policy, the so-called positive list system, to exclude drugs of low quality from the insurance-covered drug lists, but this will deal blow to small and uncompetitive players, according to a local expert.
In a recent forum, Lim Chin-gyun of Da...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
